Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 1 of 1 entries
Sorted by: Best Match Show Resources per page
Ceramide and sphingosine-1 phosphate in COPD lungs.

Thorax

Berdyshev EV, Serban KA, Schweitzer KS, Bronova IA, Mikosz A, Petrache I.
PMID: 33514670
Thorax. 2021 Jan 29; doi: 10.1136/thoraxjnl-2020-215892. Epub 2021 Jan 29.

Studies of chronic obstructive pulmonary disease (COPD) using animal models and patient plasma indicate dysregulation of sphingolipid metabolism, but data in COPD lungs are sparse. Mass spectrometric and immunostaining measurements of lungs from 69 COPD, 16 smokers without COPD...

Cite
Berdyshev EV, Serban KA, Schweitzer KS, et al. Ceramide and sphingosine-1 phosphate in COPD lungs. Thorax. 2021;doi: 10.1136/thoraxjnl-2020-215892.
Berdyshev, E. V., Serban, K. A., Schweitzer, K. S., Bronova, I. A., Mikosz, A., & Petrache, I. (2021). Ceramide and sphingosine-1 phosphate in COPD lungs. Thorax, . https://doi.org/10.1136/thoraxjnl-2020-215892
Berdyshev, Evgeny V, et al. "Ceramide and sphingosine-1 phosphate in COPD lungs." Thorax vol. (2021). doi: https://doi.org/10.1136/thoraxjnl-2020-215892
Berdyshev EV, Serban KA, Schweitzer KS, Bronova IA, Mikosz A, Petrache I. Ceramide and sphingosine-1 phosphate in COPD lungs. Thorax. 2021 Jan 29; doi: 10.1136/thoraxjnl-2020-215892. Epub 2021 Jan 29. PMID: 33514670.
Copy Download .nbib Format: NLM
Showing 1 to 1 of 1 entries